Viking Therapeutics, Inc 10-Q for FY2025 Q1
Viking Therapeutics, Inc. (VKTX)
10-Q
2025-04-24
For: 2025-03-31
View Original
Added on
April 12, 2026
About this 10-Q
Viking Therapeutics, Inc filed this 10-Q on April 24, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).
Headline figures
Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $0 a year earlier
- Net loss
- $45.63M
- compared with a net loss of $27.36M a year earlier
- Diluted EPS
- -$0.41
- compared with -$0.26 a year earlier